Fulgent Genetics Total Current Assets 2015-2024 | FLGT

Fulgent Genetics total current assets from 2015 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Fulgent Genetics Annual Total Current Assets
(Millions of US $)
2023 $508
2022 $628
2021 $612
2020 $524
2019 $37
2018 $40
2017 $33
2016 $26
2015 $3
2014 $1
Fulgent Genetics Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $327
2024-06-30 $399
2024-03-31 $387
2023-12-31 $508
2023-09-30 $550
2023-06-30 $528
2023-03-31 $581
2022-12-31 $628
2022-09-30 $697
2022-06-30 $675
2022-03-31 $765
2021-12-31 $612
2021-09-30 $623
2021-06-30 $567
2021-03-31 $659
2020-12-31 $524
2020-09-30 $196
2020-06-30 $41
2020-03-31 $37
2019-12-31 $37
2019-09-30 $39
2019-06-30 $35
2019-03-31 $36
2018-12-31 $40
2018-09-30 $41
2018-06-30 $38
2018-03-31 $36
2017-12-31 $33
2017-09-30 $32
2017-06-30 $35
2017-03-31 $33
2016-12-31 $26
2016-09-30 $17
2016-06-30 $22
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2014-12-31 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.515B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.714B 55.57
Tempus AI (TEM) United States $7.994B 0.00
Hims & Hers Health (HIMS) United States $6.961B 177.00
Inspire Medical Systems (INSP) United States $5.693B 177.56
IRhythm Technologies (IRTC) United States $3.453B 0.00
Privia Health (PRVA) United States $2.701B 225.10
Enovis (ENOV) United States $2.693B 17.94
Azenta (AZTA) United States $2.440B 130.24
Clover Health Investments (CLOV) United States $2.230B 0.00
Omnicell (OMCL) United States $2.070B 67.71
Schrodinger (SDGR) United States $1.819B 0.00
10x Genomics (TXG) United States $1.796B 0.00
Phreesia (PHR) United States $1.669B 0.00
Butterfly Network (BFLY) United States $0.748B 0.00
Standard BioTools (LAB) United States $0.588B 0.00
Talkspace (TALK) United States $0.537B 0.00
TruBridge (TBRG) United States $0.362B 105.43
Nyxoah SA (NYXH) Belgium $0.354B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Pulmonx (LUNG) United States $0.230B 0.00
American Well (AMWL) United States $0.169B 0.00
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
P3 Health Partners (PIII) United States $0.069B 0.00
CareCloud (CCLD) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
111 (YI) China $0.047B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00